A remarkable positive correlation was observed between PRR15 CNV and mRNA expression in 11 tumor types, such as ovarian serous cystadenocarcinoma, breast invasive carcinoma (BRCA), and low-grade glioma (LGG, Fig. S2e). The gene discussed is PRR15; the disease is central nervous system cancer.